Headquarters
Israel

Nanosynex

Nanosynex is developing a diagnostic test that detects bacterial resistance to antibiotics using microfluidics technology, based on research from the Technion – Israel Institute of Technology. The company’s platform aims to deliver faster and more accurate results than traditional methods, helping clinicians make timely and effective treatment decisions.

Visite el sitio web de Nanosynex

Quiénes somos

Participe en el Foro

Enlaces directos

Ediciones en otros idiomas

Política de privacidad y normas de uso

Sitemap

© 2025 Foro Económico Mundial